Sage Journals: Discover world-class research

Retricted access

Other

First published 2003-9

RETMEN2A and RETMEN2B Oncoproteins are Targets of PP1 Inhibitor

Italia Bongarzone, Cristiana Carniti, Carla Perego [...]

Tumori Journal

Free access

Review article

First published 2011-10

Thyroid cancer: pathogenesis and targeted therapy

David A. Liebner, Manisha H. Shah

Therapeutic Advances in Endocrinology and Metabolism

Free access

Review article

First published 2010-01

Review: Thyroid cancer: emerging role for targeted therapies

Jennifer A. Sipos, Manisha H. Shah

Therapeutic Advances in Medical Oncology

Retricted access

Review article

First published 2018-02

Gene Fusions in Thyroid Cancer

Valentina D. Yakushina, Larisa V. Lerner, Alexander V. Lavrov

Thyroid®

Retricted access

Research article

First published 2006-07

CpG Island Methylation of Tumor-Related Promoters Occurs Preferentially in Undifferentiated Carcinoma

Undraga Schagdarsurengin, Oliver Gimm, Henning Dralle [...]

Thyroid®

Open access

Review article

First published 2022

RET kinase inhibitors for RET -altered thyroid cancers

Danica M. Vodopivec, Mimi I. Hu

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2013-12

In Vitro and In Vivo Activity of Cabozantinib (XL184),an Inhibitor of RET,MET,and VEGFR2,in a Model of Medullary Thyroid Cancer

Frauke Bentzien, Marcus Zuzow, Nathan Heald [...]

Thyroid®

Retricted access

Research article

First published 2012-09

MicroRNA Profiles in Familial and Sporadic Medullary Thyroid Carcinoma: Preliminary Relationships with RET Status and Outcome

Caterina Mian, Gianmaria Pennelli, Matteo Fassan [...]

Thyroid®

Search results